{"id":"conventional-vincristine","safety":{"commonSideEffects":[{"rate":"30-50","effect":"Peripheral neuropathy"},{"rate":"25-40","effect":"Neutropenia"},{"rate":"30-40","effect":"Constipation"},{"rate":"20-30","effect":"Alopecia"},{"rate":"10-20","effect":"Nausea/vomiting"},{"rate":"10-20","effect":"Anemia"},{"rate":"5-10","effect":"Jaw pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vincristine inhibits the polymerization of tubulin dimers into microtubules, which are essential for mitotic spindle formation during cell division. By preventing microtubule assembly, the drug traps cells in metaphase, leading to mitotic arrest and subsequent programmed cell death. This mechanism is particularly effective against rapidly dividing cancer cells.","oneSentence":"Vincristine is a vinca alkaloid that binds to tubulin and disrupts microtubule formation, causing cell cycle arrest in metaphase and triggering apoptosis in cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:42.092Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute lymphoblastic leukemia (ALL)"},{"name":"Hodgkin lymphoma"},{"name":"Non-Hodgkin lymphoma"},{"name":"Rhabdomyosarcoma"},{"name":"Neuroblastoma"},{"name":"Wilms tumor"}]},"trialDetails":[{"nctId":"NCT02306161","phase":"PHASE3","title":"Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-12-12","conditions":"Metastatic Ewing Sarcoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Bone Marrow","enrollment":312},{"nctId":"NCT00980460","phase":"PHASE3","title":"Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-09-14","conditions":"PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma","enrollment":236},{"nctId":"NCT02166463","phase":"PHASE3","title":"Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-03-19","conditions":"Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma","enrollment":600},{"nctId":"NCT05675410","phase":"PHASE3","title":"A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-11","conditions":"Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8","enrollment":1875},{"nctId":"NCT02143414","phase":"PHASE2","title":"Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-06-30","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":53},{"nctId":"NCT07496229","phase":"PHASE1, PHASE2","title":"Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)","status":"NOT_YET_RECRUITING","sponsor":"Dizal Pharmaceuticals","startDate":"2026-03","conditions":"T-cell Lymphomas","enrollment":165},{"nctId":"NCT00379340","phase":"PHASE3","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2007-04-30","conditions":"Stage III Kidney Wilms Tumor, Stage IV Kidney Wilms Tumor","enrollment":395},{"nctId":"NCT06193759","phase":"PHASE1","title":"Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)","status":"RECRUITING","sponsor":"Children's National Research Institute","startDate":"2024-09-20","conditions":"Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS, Embryonal Tumor With Multilayered Rosettes","enrollment":12},{"nctId":"NCT06401330","phase":"PHASE3","title":"A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-04-15","conditions":"Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor, Stage III Mixed Cell Type Kidney Wilms Tumor","enrollment":1656},{"nctId":"NCT07448480","phase":"","title":"Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"Blokhin's Russian Cancer Research Center","startDate":"2026-02-01","conditions":"Recurrent Malignant Glioma, Glioblastoma, Anaplastic Astrocytoma","enrollment":1000},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":"Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma","enrollment":750},{"nctId":"NCT04322318","phase":"PHASE2","title":"A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-10-19","conditions":"Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor, Stage II Kidney Wilms Tumor","enrollment":256},{"nctId":"NCT01946529","phase":"PHASE2","title":"Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-12-27","conditions":"Desmoplastic Small Round Cell Tumor, Ewing Sarcoma of Bone or Soft Tissue, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor","enrollment":24},{"nctId":"NCT03755804","phase":"PHASE2","title":"Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2018-12-12","conditions":"Hodgkin Lymphoma","enrollment":232},{"nctId":"NCT03407144","phase":"PHASE2","title":"Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-04-09","conditions":"Hodgkin Lymphoma","enrollment":340},{"nctId":"NCT04199026","phase":"NA","title":"Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-02-25","conditions":"Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma","enrollment":20},{"nctId":"NCT00352534","phase":"PHASE3","title":"Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2006-11-06","conditions":"Stage I Kidney Wilms Tumor, Stage II Kidney Wilms Tumor, Stage III Kidney Wilms Tumor","enrollment":808},{"nctId":"NCT04994132","phase":"PHASE3","title":"A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2021-09-14","conditions":"Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma","enrollment":118},{"nctId":"NCT05535166","phase":"PHASE2","title":"Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2022-12-20","conditions":"Medulloblastoma","enrollment":130},{"nctId":"NCT04067037","phase":"PHASE2","title":"Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2019-08-26","conditions":"Classical Hodgkin Lymphoma","enrollment":60},{"nctId":"NCT01175356","phase":"PHASE1","title":"Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2011-12-21","conditions":"Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma","enrollment":99},{"nctId":"NCT00602667","phase":"PHASE2","title":"Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-12-17","conditions":"Brain and Central Nervous System Tumors","enrollment":293},{"nctId":"NCT06421948","phase":"PHASE1, PHASE2","title":"Linperlisib Combined With Chidamide in Patients With PTCL","status":"RECRUITING","sponsor":"Yanyan Liu","startDate":"2024-05-25","conditions":"Peripheral T-cell Lymphoma","enrollment":134},{"nctId":"NCT02003222","phase":"PHASE3","title":"Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-05-19","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative","enrollment":488},{"nctId":"NCT04388839","phase":"PHASE2","title":"Evolutionary Therapy for Rhabdomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2020-12-29","conditions":"Rhabdomyosarcoma","enrollment":12},{"nctId":"NCT00077285","phase":"PHASE2","title":"Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-10","conditions":"Sarcoma","enrollment":65},{"nctId":"NCT01096368","phase":"PHASE3","title":"Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2010-05-07","conditions":"Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma","enrollment":479},{"nctId":"NCT05270057","phase":"PHASE1","title":"Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2023-01-26","conditions":"B-cell Lymphoma, Burkitt Lymphoma","enrollment":11},{"nctId":"NCT03786783","phase":"PHASE2","title":"Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-03-04","conditions":"Ganglioneuroblastoma, High Risk Neuroblastoma","enrollment":42},{"nctId":"NCT07209059","phase":"PHASE2","title":"PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma","status":"RECRUITING","sponsor":"National Research Center for Hematology, Russia","startDate":"2025-07-29","conditions":"Hodgkin Lymphoma, Hodgkin Disease, Advanced Hodgkin Lymphoma","enrollment":30},{"nctId":"NCT00107198","phase":"PHASE2","title":"Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2006-01-02","conditions":"Ann Arbor Stage I Childhood Hodgkin Lymphoma, Ann Arbor Stage II Childhood Hodgkin Lymphoma, Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma","enrollment":188},{"nctId":"NCT05521087","phase":"PHASE1","title":"A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias","status":"WITHDRAWN","sponsor":"Janssen Research & Development, LLC","startDate":"2025-12-26","conditions":"Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia","enrollment":""},{"nctId":"NCT05253495","phase":"PHASE2","title":"Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma","status":"RECRUITING","sponsor":"New York Medical College","startDate":"2022-02-01","conditions":"Non-hodgkin Lymphoma, Hodgkin Lymphoma","enrollment":80},{"nctId":"NCT05008224","phase":"PHASE2","title":"Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-10-07","conditions":"Classical Hodgkin Lymphoma","enrollment":146},{"nctId":"NCT00945009","phase":"PHASE3","title":"Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2009-07-13","conditions":"Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome, Childhood Kidney Wilms Tumor","enrollment":249},{"nctId":"NCT06959732","phase":"PHASE2","title":"Zanubrutinib Combined With G-CVP in Previously Untreated FL","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-01-01","conditions":"Follicular Lymphoma ( FL)","enrollment":40},{"nctId":"NCT06954805","phase":"PHASE2","title":"Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)","status":"RECRUITING","sponsor":"Jennifer Amengual","startDate":"2025-04-14","conditions":"Lymphoma, Lymphoma, B-Cell","enrollment":30},{"nctId":"NCT06933394","phase":"PHASE2","title":"Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-05-01","conditions":"Neuroblastoma","enrollment":92},{"nctId":"NCT01478542","phase":"PHASE3","title":"OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine","status":"COMPLETED","sponsor":"Universität des Saarlandes","startDate":"2011-11","conditions":"CD20+ Aggressive B-Cell Lymphoma","enrollment":1152},{"nctId":"NCT04974216","phase":"PHASE2","title":"Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Lymphoma Academic Research Organisation","startDate":"2021-12-20","conditions":"DLBCL","enrollment":71},{"nctId":"NCT04638790","phase":"PHASE3","title":"First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)","status":"RECRUITING","sponsor":"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","startDate":"2020-02-01","conditions":"Hodgkin Lymphoma, Adult","enrollment":300},{"nctId":"NCT01798004","phase":"PHASE1","title":"Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2013-04-09","conditions":"Ganglioneuroblastoma, Stage 1 Neuroblastoma, Stage 2 Neuroblastoma","enrollment":150},{"nctId":"NCT06210750","phase":"PHASE2","title":"Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)","status":"WITHDRAWN","sponsor":"National Cancer Institute (NCI)","startDate":"2024-08-09","conditions":"T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma","enrollment":""},{"nctId":"NCT02684708","phase":"PHASE3","title":"Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Giessen","startDate":"2015-10-01","conditions":"Classical Hodgkin Lymphoma","enrollment":2200},{"nctId":"NCT06211452","phase":"PHASE3","title":"Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Grupo Argentino de Tratamiento de la Leucemia Aguda","startDate":"2007-08-01","conditions":"AML, Pediatric AML","enrollment":258},{"nctId":"NCT06201507","phase":"PHASE2","title":"BV-AVD-R Treatment Children Hodgkin's Lymphoma","status":"UNKNOWN","sponsor":"Beijing Children's Hospital","startDate":"2022-10-01","conditions":"Hodgkin Lymphoma","enrollment":44},{"nctId":"NCT01606878","phase":"PHASE1","title":"Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2013-04-29","conditions":"Childhood Solid Neoplasm, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Neuroblastoma","enrollment":46},{"nctId":"NCT06088030","phase":"PHASE2","title":"Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer","status":"RECRUITING","sponsor":"Yang Li","startDate":"2023-12-13","conditions":"Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations","enrollment":50},{"nctId":"NCT00101101","phase":"PHASE2","title":"Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2004-07","conditions":"Lymphoma","enrollment":43},{"nctId":"NCT00006734","phase":"PHASE3","title":"Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-05","conditions":"Sarcoma","enrollment":587},{"nctId":"NCT01390584","phase":"PHASE2","title":"Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma","status":"TERMINATED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2013-05-24","conditions":"Lymphoma","enrollment":6},{"nctId":"NCT00002514","phase":"PHASE3","title":"Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1993-05-07","conditions":"Leukemia","enrollment":1929},{"nctId":"NCT04480099","phase":"PHASE2","title":"Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2020-07-29","conditions":"Peripheral T-cell Lymphoma","enrollment":96},{"nctId":"NCT00549848","phase":"PHASE3","title":"Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-10-29","conditions":"Acute Lymphoblastic Leukemia","enrollment":600},{"nctId":"NCT03536039","phase":"PHASE2","title":"RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor","status":"COMPLETED","sponsor":"Andres J. M. Ferreri","startDate":"2016-01-27","conditions":"Lymphoma, Large B-Cell, Diffuse","enrollment":28},{"nctId":"NCT05428670","phase":"PHASE2","title":"The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2022-06-15","conditions":"Diffuse Large B Cell Lymphoma","enrollment":150},{"nctId":"NCT05326984","phase":"NA","title":"Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"UNKNOWN","sponsor":"Hospital General de Mexico","startDate":"2021-02-09","conditions":"Acute Lymphoblastic Leukemia","enrollment":20},{"nctId":"NCT01118026","phase":"PHASE2","title":"Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-09","conditions":"Lymphoma","enrollment":101},{"nctId":"NCT00075582","phase":"PHASE3","title":"Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-09-04","conditions":"Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma","enrollment":390},{"nctId":"NCT04992377","phase":"PHASE2","title":"R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL","status":"UNKNOWN","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2021-08-30","conditions":"Richter Transformation","enrollment":30},{"nctId":"NCT00072384","phase":"PHASE3","title":"Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2007-04-16","conditions":"Intraocular Retinoblastoma","enrollment":30},{"nctId":"NCT00002611","phase":"PHASE3","title":"Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1995-07","conditions":"Kidney Cancer","enrollment":3031},{"nctId":"NCT00004031","phase":"PHASE3","title":"SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1997-07","conditions":"Lymphoma","enrollment":397},{"nctId":"NCT00433459","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Christine Mauz-Körholz","startDate":"2007-01","conditions":"Lymphoma","enrollment":2134},{"nctId":"NCT00042367","phase":"NA","title":"Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2000-04-04","conditions":"Brain Tumors","enrollment":119},{"nctId":"NCT00354744","phase":"PHASE3","title":"High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2006-07","conditions":"Sarcoma","enrollment":109},{"nctId":"NCT00027846","phase":"PHASE2","title":"Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2003-08","conditions":"Brain Tumor, Central Nervous System Tumor","enrollment":378},{"nctId":"NCT00061893","phase":"PHASE2","title":"Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-04","conditions":"Sarcoma","enrollment":38},{"nctId":"NCT00074490","phase":"PHASE2","title":"Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-01-01","conditions":"Lymphoma, Leukemia, Myeloproliferative Disorders","enrollment":442},{"nctId":"NCT00662233","phase":"EARLY_PHASE1","title":"Combination Chemotherapy in Treating Patients With Sarcoma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"1991-10","conditions":"Ovarian Cancer, Sarcoma","enrollment":28},{"nctId":"NCT00335556","phase":"PHASE2","title":"Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2006-06","conditions":"Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney","enrollment":291},{"nctId":"NCT00088881","phase":"PHASE2","title":"Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-12","conditions":"Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma","enrollment":62},{"nctId":"NCT01279902","phase":"PHASE2","title":"Abbreviated R-CHOP in Completely Excised Stage I or II DLBCL","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2010-08","conditions":"Diffuse Large B-cell Lymphoma","enrollment":32},{"nctId":"NCT02797717","phase":"NA","title":"Treatment for Classical Hodgkin Lymphoma in Children and Adolescents","status":"RECRUITING","sponsor":"GALIA AVRAHAMI","startDate":"2015-11","conditions":"Classical Hodgkins Lymphoma in Children and Adolescents.","enrollment":2200},{"nctId":"NCT01324596","phase":"PHASE3","title":"A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib","status":"COMPLETED","sponsor":"University Hospital Southampton NHS Foundation Trust","startDate":"2011-04","conditions":"Lymphoma, Large B-Cell, Diffuse","enrollment":1132},{"nctId":"NCT00795613","phase":"PHASE2","title":"Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)","status":"UNKNOWN","sponsor":"Ospedale Santa Croce-Carle Cuneo","startDate":"2008-06","conditions":"HODGKIN LYMPHOMA","enrollment":450},{"nctId":"NCT01004497","phase":"PHASE2","title":"First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL","status":"COMPLETED","sponsor":"The Catholic University of Korea","startDate":"2010-03","conditions":"Acute Lymphoblastic Leukemia","enrollment":51},{"nctId":"NCT00072280","phase":"PHASE2","title":"Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma","status":"TERMINATED","sponsor":"Children's Oncology Group","startDate":"2004-11","conditions":"Sarcoma","enrollment":7},{"nctId":"NCT00618813","phase":"NA","title":"Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-03","conditions":"Ewing Sarcoma of Bone, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor","enrollment":35},{"nctId":"NCT01290120","phase":"PHASE2","title":"Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Northern Italy Leukemia Group","startDate":"2002-11","conditions":"Burkitt Lymphoma, B-ALL","enrollment":182},{"nctId":"NCT00003846","phase":"PHASE2","title":"Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1999-07","conditions":"Brain and Central Nervous System Tumors, Neuroblastoma","enrollment":25},{"nctId":"NCT00002610","phase":"PHASE3","title":"Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-01","conditions":"Kidney Cancer","enrollment":203},{"nctId":"NCT00002804","phase":"PHASE2","title":"Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-09","conditions":"Sarcoma","enrollment":43},{"nctId":"NCT00002740","phase":"PHASE1","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-05","conditions":"Neuroblastoma","enrollment":30},{"nctId":"NCT00003804","phase":"PHASE3","title":"Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"1993-07","conditions":"Kidney Cancer","enrollment":350},{"nctId":"NCT00030719","phase":"PHASE3","title":"Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2001-12","conditions":"Neuroblastoma","enrollment":175},{"nctId":"NCT00020566","phase":"PHASE3","title":"Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2001-02","conditions":"Sarcoma","enrollment":1200},{"nctId":"NCT00047138","phase":"PHASE3","title":"Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2001-01","conditions":"Kidney Cancer","enrollment":350},{"nctId":"NCT00003141","phase":"PHASE1","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1998-03","conditions":"Brain Tumors, Central Nervous System Tumors, Neuroblastoma","enrollment":94},{"nctId":"NCT00070200","phase":"PHASE1","title":"Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-03","conditions":"Neuroblastoma","enrollment":31},{"nctId":"NCT00017368","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-04","conditions":"Neuroblastoma","enrollment":42},{"nctId":"NCT00002803","phase":"PHASE2","title":"Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"1995-07","conditions":"Neuroblastoma","enrollment":44},{"nctId":"NCT00002802","phase":"PHASE3","title":"Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"1990-07","conditions":"Neuroblastoma","enrollment":500},{"nctId":"NCT00003015","phase":"PHASE3","title":"Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma","status":"UNKNOWN","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"1997-01","conditions":"Brain and Central Nervous System Tumors","enrollment":200},{"nctId":"NCT00002898","phase":"PHASE3","title":"Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma","status":"COMPLETED","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"1995-01","conditions":"Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma","enrollment":400},{"nctId":"NCT00025428","phase":"PHASE3","title":"Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma","status":"COMPLETED","sponsor":"Societe Internationale d'Oncologie Pediatrique","startDate":"2000-12","conditions":"Neuroblastoma","enrollment":100},{"nctId":"NCT00195871","phase":"PHASE2","title":"Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma","status":"UNKNOWN","sponsor":"Centre Henri Becquerel","startDate":"2004-02","conditions":"Lymphoblastic Lymphoma","enrollment":155},{"nctId":"NCT00276731","phase":"PHASE3","title":"Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"1995-03","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00025597","phase":"PHASE2","title":"Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.","status":"COMPLETED","sponsor":"European Infant Neuroblastoma Study Group - 1999","startDate":"1999-07","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT00025623","phase":"PHASE2","title":"Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma","status":"COMPLETED","sponsor":"European Infant Neuroblastoma Study Group - 1999","startDate":"1999-07","conditions":"Neuroblastoma","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Conventional Vincristine","genericName":"Conventional Vincristine","companyName":"Universität des Saarlandes","companyId":"universit-t-des-saarlandes","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vincristine is a vinca alkaloid that binds to tubulin and disrupts microtubule formation, causing cell cycle arrest in metaphase and triggering apoptosis in cancer cells. Used for Acute lymphoblastic leukemia (ALL), Hodgkin lymphoma, Non-Hodgkin lymphoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}